Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 26, 2021

SELL
$4.82 - $8.46 $13,978 - $24,534
-2,900 Reduced 54.72%
2,400 $12,000
Q2 2021

Jul 19, 2021

BUY
$6.81 - $9.71 $17,025 - $24,275
2,500 Added 89.29%
5,300 $44,000
Q1 2021

Apr 26, 2021

BUY
$7.45 - $12.32 $12,665 - $20,944
1,700 Added 154.55%
2,800 $24,000
Q3 2020

Oct 27, 2020

SELL
$11.73 - $16.25 $5,865 - $8,125
-500 Reduced 31.25%
1,100 $13,000
Q1 2020

May 07, 2020

SELL
$14.83 - $26.72 $2,966 - $5,344
-200 Reduced 11.11%
1,600 $24,000
Q4 2019

Feb 06, 2020

BUY
$9.77 - $24.6 $13,384 - $33,702
1,370 Added 318.6%
1,800 $44,000
Q1 2018

May 11, 2018

SELL
$12.5 - $19.75 $38,750 - $61,225
-3,100 Reduced 87.82%
430 $7,000
Q4 2017

Jan 17, 2018

BUY
$11.55 - $20.1 $39,431 - $68,621
3,414 Added 2943.1%
3,530 $44,000
Q3 2017

Oct 17, 2017

BUY
$12.7 - $19.25 $1,473 - $2,233
116
116 $2,000

About Epizyme, Inc.


  • Ticker EPZM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 168,364,992
  • Market Cap $247M
More about EPZM
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.